Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2014. Start Trial.
Date Value
November 20, 2026 3.283M
November 19, 2026 4.159M
November 18, 2026 4.120M
November 17, 2026 3.707M
November 16, 2026 6.760M
November 13, 2026 8.199M
November 12, 2026 7.940M
November 11, 2026 8.921M
November 10, 2026 8.882M
November 09, 2026 8.644M
November 06, 2026 7.837M
November 05, 2026 7.542M
November 04, 2026 8.288M
November 03, 2026 8.054M
November 02, 2026 8.152M
October 30, 2026 9.029M
October 29, 2026 8.673M
October 28, 2026 8.644M
October 27, 2026 8.309M
October 26, 2026 7.932M
October 23, 2026 7.973M
October 22, 2026 8.087M
October 21, 2026 8.801M
October 20, 2026 8.821M
October 19, 2026 9.155M
Date Value
October 16, 2026 9.521M
October 15, 2026 9.824M
October 14, 2026 9.608M
October 13, 2026 9.975M
October 12, 2026 10.02M
October 09, 2026 10.48M
October 08, 2026 10.46M
October 07, 2026 10.81M
October 06, 2026 11.66M
October 05, 2026 11.85M
October 02, 2026 11.85M
October 01, 2026 12.01M
September 30, 2026 12.05M
September 29, 2026 6.510M
September 28, 2026 5.524M
September 25, 2026 5.911M
September 24, 2026 5.380M
September 23, 2026 6.395M
September 22, 2026 7.041M
September 21, 2026 6.434M
September 18, 2026 6.044M
September 17, 2026 5.491M
September 16, 2026 5.152M
September 15, 2026 5.222M
September 14, 2026 5.316M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Omeros Corp. 1.180B
Aytu BioPharma, Inc. 20.95M
ANI Pharmaceuticals, Inc. 1.741B
Corcept Therapeutics, Inc. 6.596B
Veru, Inc. 9.969M